Cargando…
Alzheimer's disease: An evolving understanding of noradrenergic involvement and the promising future of electroceutical therapies
Alzheimer's disease (AD) poses a significant global health concern over the next several decades. Multiple hypotheses have been put forth that attempt to explain the underlying pathophysiology of AD. Many of these are briefly reviewed here, but to‐date no disease‐altering therapy has been achie...
Autores principales: | Slater, Cody, Wang, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087948/ https://www.ncbi.nlm.nih.gov/pubmed/33931975 http://dx.doi.org/10.1002/ctm2.397 |
Ejemplares similares
-
Electroceuticals in medicine – The brave new future
por: Mishra, Sundeep
Publicado: (2017) -
Electroceutical and Bioelectric Therapy: Its Advantages and Limitations
por: Jung, Bori, et al.
Publicado: (2023) -
Wearable and Implantable Electroceuticals for Therapeutic Electrostimulations
por: Long, Yin, et al.
Publicado: (2021) -
Noradrenergic therapies for apathy in Alzheimer’s disease?
por: Husain, Masud
Publicado: (2023) -
Disease-Modifying Effects of Non-Invasive Electroceuticals on β-Amyloid Plaques and Tau Tangles for Alzheimer’s Disease
por: Bok, Junsoo, et al.
Publicado: (2022)